Tirzepatide/B12 is a once-a-week injectable dual glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It works by increasing insulin production and lowering glucagon secretion as well as targets areas in the brain that regulate appetite and food intake. This works in the body by: Delaying how quickly your stomach digests food, creating a sense of fullness and satisfaction with smaller meal sizes Slows intestinal motility so you will feel fuller longer after meals Dual action receptor allows for lower blood sugars, in part by reducing the production of sugar in the liver Stimulates insulin secretion by the pancreas GIP increases energy expenditure, resulting in weight loss reductions
